Extracorporeal Membrane Oxygenation Machine Market Size to Surpass USD 689 Million by 2029 | Global Extracorporeal Membrane Oxygenation Machine Industry Trends, Share, Value, Analysis & Forecast Report by Facts & Factor
Growing adoption of ECMO in Lung Transplantation Procedures will drive significant growth in the market
/EIN News/ -- Luton, Bedfordshire, United Kingdom, Aug. 23, 2022 (GLOBE NEWSWIRE) -- Exactitude Consultancy, the market research and consulting wing of Ameliorate Digital Consultancy Private Limited has completed and published the final copy of the detailed research report on the Extracorporeal Membrane Oxygenation Machine Market.
The global extracorporeal membrane oxygenation machine market is expected to grow at a 2.41% CAGR from 2020 to 2029. It is expected to reach above USD 689 million by 2029 from USD 556 million in 2020. The ECMO market is likely to gain growth opportunities in the forecast period.
ECMO patient survival rates are based on the underlying disease and the patient’s age. VV-ECMO is indicated for patients with possibly reversible respiratory failure, such as severe acute respiratory distress syndrome (ADRs), primary graft malfunction after a lung transplant, and pulmonary trauma. Patients with respiratory failure who get VV-ECMO have a higher chance of survival. Because of its potential to assist failing circulatory systems with oxygenation functions, ECMO devices are also employed in cardiac applications. The use of these technologies for heart failure improves the chances of survival for cardiac patients. Improving survival rates with ECMO is predicted to provide the ECMO industry with favourable growth potential.
Download Full PDF Sample Copy of Report (Including Full TOC, List of Tables & Figures, Chart) at:
https://exactitudeconsultancy.com/reports/6270/extracorporeal-membrane-oxygenation-machine-market/#request-a-sample
Regional Opportunities- During the Forecast period, Asia Pacific is expected to expand the fastest. An increase in healthcare expenditure by the government and private organizations to increase healthcare facilities is one of the key factors driving the growth of this regional market. Economic development in countries such as Japan, India, and China, as well as increased government efforts connected to the development of healthcare infrastructure and reimbursement policies, are likely to boost market expansion further.
Industry Developments
- In July 2021, The National Medical Products Administration (NMPA) in China approved the Xenios Console and patient kits for ECMO therapy developed by Xenios AG (Germany).
- In February 2020, Novalung, a heart and lung support system designed to treat acute respiratory or cardiopulmonary failure, received US FDA approval from Fresenius Medical Care AG & Co. KGaA (Germany).
Extracorporeal Membrane Oxygenation Machine Market Scope and Segmentation
| REPORT METRIC | DETAILS |
| Forecast Period | 2022 to 2029 |
| Base Year | 2021 |
| Historic Years | 2021 |
| Quantitative Units | Revenue in USD Million, Volumes in Units, Pricing in USD |
| Segments Covered | by Type, by Component, by Patient Types, by Region |
| Countries Covered | U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
| Market Players Covered | Fresenius Medical care AG & Co. KGaA, Getinge Group, Medtronic plc; Sorin Group, Terumo Cardiovascular Systems Corporation, MAQUET Holding B.V. & Co. KG, Medos Medizintechnik AG, Nipro Medical Corporation, Microport Scientific Corporation |
| market growth | The rising frequency of target illnesses increased need for early detection and diagnostic imaging, and technical improvements in the ECMO machine market all contribute to the industry’s growth. Furthermore, the increased prevalence of lung disorders such as TB, thoracic malignancies, osteoporosis, fractures, and CVDs raises the demand for diagnostic medical imaging. |
Browse Detailed Research Insights with TOC:
https://exactitudeconsultancy.com/reports/6270/extracorporeal-membrane-oxygenation-machine-market/
The ECMO market is likely to gain growth opportunities in the forecast period.
ECMO patient survival rates are based on the underlying disease and the patient’s age. VV-ECMO is indicated for patients with possibly reversible respiratory failure, such as severe acute respiratory distress syndrome (ADRs), primary graft malfunction after a lung transplant, and pulmonary trauma. Patients with respiratory failure who get VV-ECMO have a higher chance of survival. Because of its potential to assist failing circulatory systems with oxygenation functions, ECMO devices are also employed in cardiac applications. The use of these technologies for heart failure improves the chances of survival for cardiac patients. Improving survival rates with ECMO is predicted to provide the ECMO industry with favourable growth potential.
Key Market Segments: Extracorporeal Membrane Oxygenation Machine Market
Extracorporeal Membrane Oxygenation Machine Market by Type, 2020-2029, (USD Millions, Thousand Units)
- ECMO MACHINES
- Software
Extracorporeal Membrane Oxygenation Machine Market by Component, 2020-2029, (USD Millions, Thousand Units)
- Pumps
- Oxygenators
- Controllers
- CANNULA
- Accessories
Extracorporeal Membrane Oxygenation Machine Market by Patient Types, 2020-2029, (USD MILLIONS, Thousand Units)
- Pediatrics
- Adults
Important Features that are under offering & key highlights of the report:
- Detailed overview of Extracorporeal Membrane Oxygenation Machine Market
- Changing market dynamics of the industry
- In-depth market segmentation by Type, Application etc
- Historical, current and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape of Aloe Vera market
- Strategies of key players and product offerings
- Potential and niche segments/regions exhibiting promising growth
- A neutral perspective towards Aloe Vera market performance
- Extracorporeal Membrane Oxygenation Machine Market player’s information to sustain and enhance their footprint
- What are the market factors that are explained in the report?
Finally, researchers throw light on the pinpoint analysis of Global Electric Vehicle Battery Market dynamics. It also measures the sustainable trends and platforms which are the basic roots behind the market growth. The degree of competition is also measured in the research report. With the help of SWOT and Porter’s five analysis, the market has been deeply analyzed. It also helps to address the risk and challenges in front of the businesses. Furthermore, it offers extensive research on sales approaches.
Browse Latest research Reports by Exactitude Consultancy:
North America Active Wheelchair Market
The North America Active Wheelchair Market is expected to grow at more than 7.7% CAGR from 2019 to 2028. It is expected to reach above USD 970 million by 2028 from a little above USD 502 million in 2019.
https://exactitudeconsultancy.com/reports/789/north-america-active-wheelchair-market/
Electronic Drug Delivery Systems Market
The Global Electronic Drug Delivery Systems Market is expected to grow at 8.1% CAGR from 2019 to 2028. It is expected to reach above USD 14.36 million by 2028 from USD 7.50 million in 2019.
https://exactitudeconsultancy.com/reports/1262/electronic-drug-delivery-systems-market/
Infusion Pumps Market
The Global Infusion Pumps Market is expected to grow at more than 9.6% CAGR from 2019 to 2028. It is expected to reach above USD 24.57 billion by 2028 from a little above USD 11.30 billion in 2019.
https://exactitudeconsultancy.com/reports/1224/infusion-pumps-market/
Irfan Tamboli (Head of Sales) - Exactitudeconsultancy
Phone: + 1704 266 3234
sales@exactitudeconsultancy.com
LinkedIn: https://www.linkedin.com/company/exactitudeconsultancy/
EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.
